Moleculin Biotech, Inc., (NASDAQ: MBRX) announced the pricing of an underwritten public offering of securities for gross proceeds of approximately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE